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♦ Introduction: Diabetes mellitus is a leading cause of chronic 
renal failure, challenging therapy strategies. Patients with 
diabetes may benefit from peritoneal dialysis (PD) but higher 
technique failure is feared. Our purpose was to critically evalu-
ate clinical outcomes of this modality in diabetics, in order to 
find quality improvement strategies in these risk patients.
♦ Methods: A registry-based study of 432 incident patients, 
23% with diabetes, from a university hospital PD program 
was performed. Traditional methods (Kaplan-Meier, Cox 
models) and innovative survival analysis, taking competing 
risks into account, were performed, as well as exploring the 
trends in cohorts according to the decade of PD start.
♦ Results: In spite of the detrimental effect of diabetes 
in patient survival compared to non-diabetics (77%, 52% 
vs 86%, 71%, at 2 and 4 years, respectively; p < 0.0001) 
the hazard ratio (HR) for death decreased in the more 
contemporary cohort (0.303, 95% confidence interval (CI) 
0.150 – 0.614, p < 0.001). It is noteworthy that diabetes 
was not associated with lower technique survival: 74%, 
51% vs 79%, 57%, at 2 and 4 years, respectively (p = not 
significant (NS)). On multivariate analysis, diabetes was 
an independent predictor for mortality, but not for tech-
nique failure. The hazard ratio (HR) for technique failure 
also decreased in the more recent cohort (0.566, 95% CI 
0.348 – 0.919, p = 0.021).
Among reasons for transfer to hemodialysis, proportion of 
ultrafiltration failure was similar between groups (26% vs 
22%, p = NS), but drop-out due to loss of autonomy occurred 
more in the group with diabetes (23% vs 5%, p = 0.004), 
mainly due to ischemic stroke. The hospitalization rate was 
also higher in diabetic patients (1.39 vs 0.84 episodes per 
patient-year (E/PY), p = 0.004) but the peritonitis rate was 
not increased (0.53 vs 0.61 E/PY, p = NS).
♦ Conclusion: PD was an effective long-term renal 
replacement therapy in diabetics, without higher rates of 
technique failure, ultrafiltration failure or peritonitis. Bet-
ter outcomes were achieved in the contemporary cohort. The 
menace of autonomy loss due to stroke and higher hospi-
talization rates enhance the need for assisted PD strategies 
and better control of comorbidities.
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The incidence and prevalence of diabetes mellitus (DM) is estimated to continue to rise worldwide (1,2). Diabetic 
patients face the worst survival (3) both on hemodialysis 
(HD) and peritoneal dialysis (PD) and represent a chal-
lenge to the healthcare team. Debate considering which 
dialysis modality confers better survival to diabetics still 
remains, with conflicting reports (4,5).
In the earlier days of PD, diabetic status was a fac-
tor in choosing the technique due to the importance of 
better hemodynamic stability, few episodes of hemor-
rhagic ocular complications and the feasibility of elective 
intra- peritoneal insulin. Avoidance of vascular access com-
plications and benefits of the preservation of residual renal 
function were also relevant. However, today many clinicians 
fear  proposing PD to their diabetic patients because of a 
presumed higher risk of peritonitis, ultrafiltration failure, 
metabolic and nutritional deleterious consequences, even 
though myths might be stronger than facts (6–9). 
We undertook this study to analyze the long-term PD 
treatment of diabetic patients, investigating achieved 
patient and technique survivals, causes of drop-out, 
and rates of peritonitis and hospitalization, as well as 
the trend of survival in cohorts of patients according 
to the period of PD start. Moreover, a more accurate 
methodological statistical method was applied to analyze 
major outcomes facing competing events such as access 
to transplantation or change of modality.
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PATIENTS AND METHODS
We retrospectively reviewed the registry data of 
consecutive adult incident PD patients, in a University 
Hospital PD Unit – Hospital de Santo António, Porto –, 
admitted from October 1985 through June 2010. Data 
included demographic and clinical information prospec-
tively collected as an instrument of continuous quality 
control in the Unit. Seven of the 439 incident patients 
were excluded from this analysis: 4 because of missing 
data and 3 who were lost to follow-up after transfer to 
another center. We then considered a total population of 
432 patients, 11,640 months at risk. The diabetic group 
consisted of 101 patients (23.4%), of whom 50 (49.5%) 
had type 2 diabetes.
Basal data included demographics, reason for PD 
(option/vascular access failure), previous renal replace-
ment therapy (RRT) [PD-first, HD, renal transplantation 
(RT)] and previous total time on RRT. Survival analysis 
focused on patient and technique survival. Death within 
30 days after transfer to HD was assigned to PD. Causes 
of death were grouped into cardiovascular, infection 
related to PD technique, infection not related to PD 
technique, other and unknown. Causes of transfer to HD 
were grouped into infection (peritonitis, tunnel and exit-
site infection), inadequate dialysis (dose/ultrafiltration 
failure), loss of autonomy for technique, psychosocial 
(PD burn-out/logistic) and abdominal complications 
(catheter and mechanical problems, acute abdomen).
Peritonitis and hospitalization episodes were regis-
tered for each patient; global rates for groups with DM 
and without DM were calculated, presented as episodes/
patient-year (E/PY). 
STATISTICAL ANALYSIS
Continuous variables data were presented, according 
to the distribution, as mean and standard deviations or 
as median and inter-quartile (IQ) ranges and compared 
between groups using student t-test and Mann-Whitney 
U test respectively. Categorical variables were expressed 
as absolute and relative frequencies and chi-square test 
was applied to compare proportions between diabetic 
and non-diabetic. For survival analysis, the Kaplan-Meier 
log-rank test and the Cox proportional hazard model 
were used in order to compare our results with those of 
previous studies in this area. These outcomes were also 
explored according to diabetes type 1 versus type 2. 
Additionally, survival analysis taking competing risks 
into account was used to report patient and technique 
survivals. For patient survival, the event of interest was 
death, and both RT and transfer to HD were considered 
as competing events. For technique survival, the event 
of interest was transfer to HD, and both death and RT 
were considered competing events. Cumulative inci-
dence, defined as the probability that an individual will 
experience a specific event by time t, was determined. 
A Gray’s test was used to compare patient and technique 
survival between subgroups. Multivariate models were 
used to analyze death and the technique failure hazard 
ratio (HR) according to the period of PD start (period 1: 
1985 – 1994; period 2: 1995 – 2004; period 3: > 2004). 
Poisson models were applied to compare rates of perito-
nitis and hospitalization.
The statistical analyses were performed using SPSS, 
version 17.0 (SPSS Inc., Chicago) and R. Significance was 
assumed at a p level less than 0.05. 
RESULTS
PATIENT CHARACTERISTICS AT BASELINE
Characteristics at  admission to the PD program of the 
total population and the comparison between diabetic 
and non-diabetic patients are presented in Table 1. Age, 
percentage of patients older than 65 years, gender, 
reason for PD and previous RRT technique did not sig-
nificantly differ between groups. It is noteworthy that 
the diabetic group had a significantly lower RRT vintage, 
when compared to the counterpart group [33 months 
(15 – 99) vs 75 months (23 – 125); p = 0.05]. In addition, 
PD represented the first RRT modality in more than half 
of the diabetics (64%). 
PATIENT AND TECHNIQUE SURVIVALS AND CLINICAL REASONS 
FOR DROP-OUT
Median follow-up time for the entire population was 
20.7 months (IQ range 7.5 – 38.3). At the end of the 
study, a total of 360 patients discontinued PD treatment, 
89 (88%) diabetics and 271 (82%) non-diabetics without 
major differences in cause of death or transfer to HD 
among the groups (Table 2). 
It is noteworthy that diabetic patients did not show a 
higher proportion of peritonitis or inadequate dialysis as 
causes of drop-out. However, loss of autonomy for self-
care dialysis was a relevant cause in patients with DM 
(22.9% vs 5.2% in non-diabetics; p = 0.004), mainly due 
to ischemic stroke (4 cases). Severe peripheral arteriopa-
thy (2 cases), frailty after myocardial infarction (1 case) 
or progressive diabetic retinopathy (1 case) were also 
causes of loss of capacity for auto-dialysis in diabetics. 
On the other hand, in the non-diabetic group the causes 
of loss of autonomy as a reason for drop-out included 
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cachexia (1 case), mental disease (1 case), frailty associ-
ated with aging (2 cases) and stroke (1 case).
A lower proportion of diabetics received a renal graft 
during the follow-up (19% vs 32%; p = 0.016).
A Kaplan-Meier analysis showed significantly lower 
global survival in diabetic patients than their counterparts 
at 1, 2, 3 and 4 years: 89%, 77%, 67%, 52% vs 93%, 86%, 
79%, 71%, respectively (p < 0.001). However, considering 
technique survival, we found similar  proportions between 
groups, also at 1, 2, 3 and 4 years: 84%, 74%, 66%, 51% 
vs 87%, 79%, 66%, 57%, respectively (p = NS) (Figure 1). 
When exploring the impact of diabetes on these major 
outcomes, a significant difference in mortality or drop-
out was not found between subgroups of type 1 versus 
type 2 diabetes. Patient survival averaged 41 ± 3.8 vs 
47 ± 6.5 months (p = 0.96) and technique survival 37 ± 
4.3 vs 54 ± 8.3 months (p = 0.194) in type 1 and type 2 
diabetes groups, respectively. However, a higher propor-
tion of patients in the type 2 diabetes group suffered 
from peritonitis and hospital admissions (peritonitis 56% 
vs 41%, p = 0.09; technique related admissions 78% vs 
58%, p = 0.03; non technique related admissions 52% vs 
41%, p = 0.18). 
In a multivariable analysis (Cox) including diabetes, 
gender, elderly status (> 65 years), PD after HD and PD 
after transplantation in the model, DM was an independent 
predictor for patient mortality (HR 2.3; 95% CI 1.5 – 3.7) 
but not for technique failure (HR 1.3; 95% CI 0.9 – 1.9).
TABLE 1 
Characteristics of Diabetic and Non-Diabetic Patients at Baseline
  Total Diabetics Non-Diabetics p
n (%) 432 (100) 101 (23.4) 331 (76.6) -
Age (mean, years) 48.5±15.7 49.7±15.9 48.2±15.7 NS
Elderly (n, %) 70 (16.2) 18 (17.8) 52 (15.7) NS
Male (n, %) 166 (38.4) 47 (46.5) 119 (36.0) NS
Previous RRT    NS
 PD-first (n, %) 233 (53.9) 65 (64.4) 168 (50.8) 
 HD (n, %) 148 (34.3) 26 (25.7) 122 (36.9) 
 Transplantation (n, %) 51 (11.8) 10 (9.9) 41 (12.4) 
PD by option (n, %) 240 (55.6) 57 (56.8) 183 (55.4) NS
RRT vintage (median, months)  33 (15–99) 75 (23–125) 0.05
PD = peritoneal dialysis; HD = hemodialysis; RRT = renal replacement therapy; NS = not significant.
TABLE 2 
Causes of Drop-Out in Diabetic and Non-Diabetic Patients
   Total Diabetics Non-diabetics 
  Causes of drop-out  (n=432) (n=101) (n=331) p
Death 94 (26.1%) 33 (37.1%) 61 (22.5%) 0.012
 Cardiovascular      55 (58.5%)  20 (60.6%)  35 (57.4%) NS
 Infection/technique        9 (9.6%)   2 (6.1%) 7 (11.4%) NS
 Infection/non-technique 9 (9.6%)   4 (12.1%) 5 (8.2%) NS
 Other 14 (14.9%)  4 (12.1%) 10 (16.4%) NS
 Unknown 7 (7.4%) 3 (9.1%) 4 (6.6%) NS
Hemodialysis 151 (41.9%)  35 (39.3%) 116 (42.8%) NS
 Infection 67 (44.4%)  11 (31.4%) 56 (48.3%) NS
 Underdialysis/ultrafiltration failure 35 (23.2%)  9 (25.7%) 26 (22.4%) NS
 Loss of autonomy for technique 14 (9.3%) 8 (22.9%) 6 (5.2%) 0.004
 Psychosocial 8 (5.3%)   1 (2.9%) 7 (6.0%) NS
 Abdominal complications 26 (17.2%) 5 (14.3%) 21 (18.1%) NS
Renal transplantation 104 (28.9%) 17 (19.1%) 87 (32.1%) 0.016
Renal function recovery 11 (3.1%) 4 (4.5%) 7 (2.6%) NS
NS = not significant.
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contemporary (> 2004) cohort (Table 3). Additionally, 
the model revealed that PD as first dialysis modality is 
beneficial in comparison with PD after HD. 
PERITONITIS AND HOSPITALIZATION RATES
The global peritonitis rate was similar between dia-
betic and non-diabetic groups (0.53 vs 0.61 E/PY; p = NS). 
The global hospitalization rate was significantly higher 
in patients with DM than in their counterparts (1.39 vs 
0.84 E/PY; p = 0.004).
DISCUSSION
In line with the current debate concerning the low 
levels of admission of diabetic patients to PD programs, 
These results were reproduced after taking competing 
events into account, as a more appropriate statistical 
approach. The probability of death and transfer to HD 
(cumulative incidence) by diabetic status are depicted in 
Figure 2. The probability of death and transfer for HD by 
1, 3 and 4 years after starting peritoneal dialysis was 8%, 
20%, 24% and 13%, 26%, 31% respectively. Diabetes was a 
significant predictor for death on PD (p < 0.001), but was not 
a predictor of technique failure (p > 0.516). Also age > 65 was 
a significant predictor for death, as expected, but was not a 
predictor of technique failure. Thus, after considering the 
competing risk of death and access to transplantation, aged 
patients do not have higher risk of PD technique failure. 
By using a multivariate competing risk analysis, it 
was shown that the hazard ratio for both death and 
technique failure decreased from the remote to the more 
Figure 2 — Cumulative incidence estimates by diabetes status taking competing risks in account for (A) Technique failure (Gray’s 
test p=0.516) and (B) Patient death (Gray’s test p<0.001).
Figure 1 — Kaplan-Meier curves by diabetic status for (A) Technique survival (log rank p=NS) and (B) Patient survival (log rank 
p<0.0001).
(A) (B)
(A) (B)
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our study adds a favorable report of long-term treatment 
of diabetic patients with PD. By reanalyzing the out-
comes in this high-risk group of patients with different 
perspectives and appropriate methodologies, we docu-
ment contemporary improvements and point to areas of 
further investment.
Our global patient survival rates in the DM group 
compare favorably with data from the EDTA registry (3) 
and the USRDS 2010 (1). Focusing on a population that 
 mimics the average age of our treated patients, in the 
French PD registry, DM patients aged 50 – 60 years had 
lower three-year patient and technique survivals, report-
ed as 59% and 34%, respectively (10). Better results are 
achievable with contemporary PD prescription (11). We 
documented in our study that the cohort that began PD 
after 2004 showed lower hazards for both death and tech-
nique failure in a multivariate analysis. The innovative 
additional methodological approach, taking into account 
competing risks events, constitutes an added value of 
this study. Access to RT is a relevant competing event and 
in commonly reported survival analysis this has not been 
taken into account (12). RT was a major cause of drop-out 
in our study, lowest in diabetic patients when compared 
to non-diabetics. This current approach updated coher-
ently the classical Kaplan-Meier results. 
As expected, in our population, DM was associated 
with higher mortality (especially cardiovascular) and 
hospitalization rates. Baseline comorbidity and a higher 
rate of previous cardiovascular events in diabetics may 
explain this difference (11,13). Other reasons might be 
the variations in fluid homeostasis and corporal compo-
sition in diabetic patients, as fluid overload is the main 
cause of cardiovascular death in end-stage renal disease 
patients, and fluid control is potentially more difficult in 
PD diabetic patients (5), especially after losing residual 
renal function. 
Despite the higher mortality of diabetics whichever 
the modality, we did not find significantly more deaths 
or PD failure in the type 2 DM group. In fact, type 2 DM 
patients, particularly older female patients, could pres-
ent more cardiovascular complications associated with 
obesity, inflammation and atherosclerosis. On the other 
hand, younger type 1 DM patients often suffer from dif-
ficult glycemic control and hypervolemia. Therapy skills, 
including elective icodextrin and automated peritoneal 
dialysis (APD) prescription while avoiding glucose load 
might have conditioned our favorable results (14).
Our study showed a similar rate of technique failure 
between groups, refuting the association of diabetes 
with more peritonitis or ultrafiltration failure. Instead, 
a higher proportion of diabetic patients lost capacity for 
self-dialysis, mainly due to ischemic stroke, an aspect 
that has not been previously highlighted (15). This can 
be explained by progressive diabetic micro- and mac-
roangiopathic complications inherent to most of these 
patients, such as retinopathy, neuropathy and cerebro-
vascular disease. Our study underlines the importance of 
careful management of this complication and also calls 
for assisted PD strategies.
Our study also enabled us to document a major issue: 
PD represented the first RRT modality in more than half 
of the group with DM. This finding constitutes a stimu-
lus to offer the benefits of a PD-first approach in these 
patients (16), especially since  our model pointed to a 
less advantageous effect of PD after HD.
Some limitations in our study are recognized. 
Extending our results to the population currently in 
treatment in Western countries is limited by some of its 
characteristics, such as the age of its population, which 
is younger than current standards in some countries, 
the high percentage of patients arriving from another 
treatment, and the lack of detailed comorbidity data. 
TABLE 3 
Multivariate Competing Risk Models: Improved Outcomes in Contemporary PD Cohorts
 Death Technique
 Exp (coef) 95% CI p Exp (coef) 95% CI p
Diabetes (Y) 1.926 1.244–2.982 0.003 0.987 0.659–1.479 0.950
Age (>65) 4.117 2.640–6.419 <0.001 0.680 0.418–1.105 0.120
PD after HD*  1.563 1.012–2.414 0.04 1.408 0.987–2.007 0.059
PD after RT* 2.011 0.976–4.144 0.06 1.366 0.836–2.233 0.210
Cohort (1995–2004)** 1.050 0.649–1.698 0.840 0.895 0.611–1.311 0.570
Cohort (=>2004)** 0.303 0.150–0.614 <0.001 0.566 0.348–0.919 0.021
CI = confidence interval; PD = peritoneal dialysis; HD = hemodialysis; RT = renal transplantation.
*PD first group.
** Cohort 1985–1994.
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However, single-center studies reports are relevant to 
identify specific center characteristics with impact on 
patient and technique outcome (17). 
To conclude, despite the known detrimental effect of 
DM on patient survival, improvements were progressively 
documented up to the contemporary period. The modality 
is an effective RRT option in diabetic patients, without 
significantly higher technique failure or peritonitis rate. 
However, loss of autonomy for self-care dialysis was 
proportionally higher in diabetics. Furthermore, this 
study highlights the relevance of continued detailed 
prospective data collection to internal quality control 
assessment and external center experience reports. 
Major outcomes such as mortality and technique survival 
should preferably be reported by using competing risk 
analysis in populations with variable access to renal 
transplantation and modality transfer.
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